AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,000 | 0.0% | 626 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $18,000 | -57.1% | 626 | -47.4% | 0.00% | -50.0% |
| Q1 2019 | $42,000 | 0.0% | 1,189 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $42,000 | -36.4% | 1,189 | +10.1% | 0.00% | -50.0% |
| Q3 2018 | $66,000 | -12.0% | 1,080 | -2.7% | 0.00% | -50.0% |
| Q2 2018 | $75,000 | +4.2% | 1,110 | -15.8% | 0.01% | – |
| Q1 2018 | $72,000 | +188.0% | 1,318 | +214.6% | 0.00% | -100.0% |
| Q4 2017 | $25,000 | -58.3% | 419 | +8.0% | 0.00% | -75.0% |
| Q3 2017 | $60,000 | -16.7% | 388 | -71.8% | 0.00% | -50.0% |
| Q2 2017 | $72,000 | +1100.0% | 1,378 | +928.4% | 0.01% | +700.0% |
| Q1 2017 | $6,000 | – | 134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |